FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366978207> ?p ?o ?g. }

• W4366978207 endingPage "101559" @default.
• W4366978207 startingPage "101559" @default.
• W4366978207 abstract "The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has particularly impacted patients with hemato-oncological malignancies, as they showed not only a higher propensity for severe courses but also weaker immune responses after vaccination. Still, data on the influence of pandemic waves and vaccinations on outcomes are rare. This study aimed to analyze the timely course of infections and vaccinations in a real-life cohort of patients with hemato-oncological diseases.In this cohort study, 1817 patients with hemato-oncological diseases from 1 February 2020 to 15 December 2022 at the 'Franz Tappeiner' Hospital in Merano/Meran, Italy, were followed for SARS-CoV-2 infections and vaccinations.Of 1817 patients with hemato-oncological malignancies, 735 (40.5%) were infected at least once with SARS-CoV-2, and 1614 (88.8%) received one or more doses of the approved vaccinations. Patients receiving antineoplastic treatment had a lower SARS-CoV-2 infection rate [35.1% versus 41.0%; odds ratio (OR) 0.78, 95% confidence interval (CI) 0.64-0.95], but higher risk of hospitalization (13.4% versus 6.9%; OR 2.11, 95% CI 1.25-3.69) compared with untreated patients. Overall, the case fatality rate (CFR) was 3.4%. Unvaccinated patients were more prone to severe coronavirus disease 2019 (COVID-19) courses requiring hospitalization (OR 2.34, 95% CI 1.25-4.36) and had a higher CFR (7.3% versus 1.6%; OR 4.98, 95% CI 2.16-12.98) than their vaccinated counterparts. In the Delta wave, patients with two vaccinations had a lower infection risk (OR 0.18, 95% CI 0.10-0.35) and tendentially lower hospitalization rates (OR 0.25, 95% CI 0.05-1.29) than unvaccinated patients. In the Omicron wave, 345/1198 (28.8%) patients with three or more vaccinations had breakthrough infections, resulting in a similar risk for infection (OR 0.88, 95% CI 0.60-1.30) but numerically lower risk for hospitalization (24/345, 7.0%) than unvaccinated individuals (4/40, 10.0%). Scheduled visits were postponed in 128/335 (38.2%) patients due to COVID-19, and deferrals correlated with pandemic wave (P = 0.002) and vaccination status (P < 0.001).SARS-CoV-2 infections and outcomes differ between distinct phases of the pandemic. Vaccination with variant-specific vaccines should be prioritized as general protective measures are increasingly lifted." @default.
• W4366978207 created "2023-04-27" @default.
• W4366978207 creator A5018903381 @default.
• W4366978207 creator A5041563953 @default.
• W4366978207 creator A5052369482 @default.
• W4366978207 creator A5057141936 @default.
• W4366978207 creator A5077712742 @default.
• W4366978207 creator A5086579607 @default.
• W4366978207 date "2023-06-01" @default.
• W4366978207 modified "2023-09-26" @default.
• W4366978207 title "Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort" @default.
• W4366978207 cites W2029445248 @default.
• W4366978207 cites W2605343262 @default.
• W4366978207 cites W3006355661 @default.
• W4366978207 cites W3008090866 @default.
• W4366978207 cites W3012268121 @default.
• W4366978207 cites W3017734961 @default.
• W4366978207 cites W3019820338 @default.
• W4366978207 cites W3111255098 @default.
• W4366978207 cites W3111590711 @default.
• W4366978207 cites W3130161221 @default.
• W4366978207 cites W3153280867 @default.
• W4366978207 cites W3182782630 @default.
• W4366978207 cites W3184498267 @default.
• W4366978207 cites W3196336490 @default.
• W4366978207 cites W3202209604 @default.
• W4366978207 cites W3209203499 @default.
• W4366978207 cites W3210005297 @default.
• W4366978207 cites W3210973670 @default.
• W4366978207 cites W3215610096 @default.
• W4366978207 cites W4205483821 @default.
• W4366978207 cites W4206987853 @default.
• W4366978207 cites W4210481577 @default.
• W4366978207 cites W4220932802 @default.
• W4366978207 cites W4223423566 @default.
• W4366978207 cites W4224282043 @default.
• W4366978207 cites W4224950216 @default.
• W4366978207 cites W4225818281 @default.
• W4366978207 cites W4226192094 @default.
• W4366978207 cites W4280491077 @default.
• W4366978207 cites W4281251564 @default.
• W4366978207 cites W4281648196 @default.
• W4366978207 cites W4295094939 @default.
• W4366978207 cites W4313278417 @default.
• W4366978207 cites W4318693372 @default.
• W4366978207 doi "https://doi.org/10.1016/j.esmoop.2023.101559" @default.
• W4366978207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37196399" @default.
• W4366978207 hasPublicationYear "2023" @default.
• W4366978207 type Work @default.
• W4366978207 citedByCount "0" @default.
• W4366978207 crossrefType "journal-article" @default.
• W4366978207 hasAuthorship W4366978207A5018903381 @default.
• W4366978207 hasAuthorship W4366978207A5041563953 @default.
• W4366978207 hasAuthorship W4366978207A5052369482 @default.
• W4366978207 hasAuthorship W4366978207A5057141936 @default.
• W4366978207 hasAuthorship W4366978207A5077712742 @default.
• W4366978207 hasAuthorship W4366978207A5086579607 @default.
• W4366978207 hasBestOaLocation W43669782071 @default.
• W4366978207 hasConcept C107130276 @default.
• W4366978207 hasConcept C126322002 @default.
• W4366978207 hasConcept C156957248 @default.
• W4366978207 hasConcept C187212893 @default.
• W4366978207 hasConcept C187316915 @default.
• W4366978207 hasConcept C201903717 @default.
• W4366978207 hasConcept C203014093 @default.
• W4366978207 hasConcept C22070199 @default.
• W4366978207 hasConcept C2779134260 @default.
• W4366978207 hasConcept C3008058167 @default.
• W4366978207 hasConcept C44249647 @default.
• W4366978207 hasConcept C524204448 @default.
• W4366978207 hasConcept C71924100 @default.
• W4366978207 hasConcept C72563966 @default.
• W4366978207 hasConcept C89623803 @default.
• W4366978207 hasConceptScore W4366978207C107130276 @default.
• W4366978207 hasConceptScore W4366978207C126322002 @default.
• W4366978207 hasConceptScore W4366978207C156957248 @default.
• W4366978207 hasConceptScore W4366978207C187212893 @default.
• W4366978207 hasConceptScore W4366978207C187316915 @default.
• W4366978207 hasConceptScore W4366978207C201903717 @default.
• W4366978207 hasConceptScore W4366978207C203014093 @default.
• W4366978207 hasConceptScore W4366978207C22070199 @default.
• W4366978207 hasConceptScore W4366978207C2779134260 @default.
• W4366978207 hasConceptScore W4366978207C3008058167 @default.
• W4366978207 hasConceptScore W4366978207C44249647 @default.
• W4366978207 hasConceptScore W4366978207C524204448 @default.
• W4366978207 hasConceptScore W4366978207C71924100 @default.
• W4366978207 hasConceptScore W4366978207C72563966 @default.
• W4366978207 hasConceptScore W4366978207C89623803 @default.
• W4366978207 hasIssue "3" @default.
• W4366978207 hasLocation W43669782071 @default.
• W4366978207 hasLocation W43669782072 @default.
• W4366978207 hasLocation W43669782073 @default.
• W4366978207 hasOpenAccess W4366978207 @default.
• W4366978207 hasPrimaryLocation W43669782071 @default.
• W4366978207 hasRelatedWork W1980275360 @default.
• W4366978207 hasRelatedWork W2001108036 @default.
• W4366978207 hasRelatedWork W2049342566 @default.
• W4366978207 hasRelatedWork W2071781463 @default.

• next